Stocks Health care AAPG
NASDAQ · Health careAscentage Pharma Group International (AAPG)
Ascentage Pharma Group International reported revenue of $134.3M in fiscal 2024. It posted a net loss of $55.5M. In fiscal 2024 capital spending exceeded operating cash flow by $18.6M. At December 31, 2024 it held $122.4M in cash against $228.6M of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 29, 2026.
What Ascentage Pharma Group International does
Ascentage Pharma Group International is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker AAPG.
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | $134.3M | -$55.5M | -$0.18 | -$18.6M |
Latest SEC filings
What Ascentage Pharma Group International has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 17, 2026
- August 20, 2026
- August 13, 2026
- August 5, 2026
- August 3, 2026
- July 27, 2026
- July 20, 2026
- July 20, 2026Form F-3ASR filing F-3ASR
- July 13, 2026
- June 30, 2026
Questions about AAPG
What does Ascentage Pharma Group International do?
Ascentage Pharma Group International is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker AAPG.
Is Ascentage Pharma Group International profitable?
No. In fiscal 2024 it reported a net loss of $55.5M on revenue of $134.3M.
How much revenue does Ascentage Pharma Group International make?
In fiscal 2024 Ascentage Pharma Group International reported revenue of $134.3M.
When did Ascentage Pharma Group International last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 29, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 17, 2026.
Similar companies
Follow AAPG
Get an email when Ascentage Pharma Group International files with the SEC: results, executive changes, material agreements and annual reports.
Follow AAPG: get an email when it filesWhere the numbers come from
Financial figures are the values Ascentage Pharma Group International tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.